Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Sees Significant Drop in Short Interest

Carl Zeiss Meditec AG (OTCMKTS:CZMWYGet Free Report) was the target of a large drop in short interest in October. As of October 15th, there was short interest totaling 900 shares, a drop of 71.9% from the September 30th total of 3,200 shares. Based on an average daily volume of 4,800 shares, the days-to-cover ratio is presently 0.2 days. Based on an average daily volume of 4,800 shares, the days-to-cover ratio is presently 0.2 days.

Carl Zeiss Meditec Stock Down 1.2%

Shares of OTCMKTS CZMWY opened at $51.95 on Wednesday. The firm’s 50-day moving average price is $51.45 and its 200-day moving average price is $59.05. Carl Zeiss Meditec has a 52-week low of $46.13 and a 52-week high of $76.28.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the stock. Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Carl Zeiss Meditec in a research note on Tuesday, August 12th. Barclays assumed coverage on shares of Carl Zeiss Meditec in a report on Tuesday, September 9th. They set an “overweight” rating on the stock. Two research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Carl Zeiss Meditec currently has a consensus rating of “Hold”.

Read Our Latest Stock Report on CZMWY

Carl Zeiss Meditec Company Profile

(Get Free Report)

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.

Featured Stories

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.